Found: 67
Select item for more details and to access through your institution.
Frontispiz: Photochemische Konjugation und Eintopfradiomarkierung von Antikörpern für Immun‐PET.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 7, p. N.PAG, doi. 10.1002/ange.201980761
- By:
- Publication type:
- Article
Photochemische Konjugation und Eintopfradiomarkierung von Antikörpern für Immun‐PET.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 7, p. 1946, doi. 10.1002/ange.201813287
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2018, v. 61, n. 9, p. i, doi. 10.1002/jlcr.3670
- By:
- Publication type:
- Article
Antibody‐based radiopharmaceuticals for imaging and therapy.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Chemical aspects of metal ion chelation in the synthesis and application antibody‐based radiotracers.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2018, v. 61, n. 9, p. 652, doi. 10.1002/jlcr.3590
- By:
- Publication type:
- Article
Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2014, v. 57, n. 4, p. 323, doi. 10.1002/jlcr.3158
- By:
- Publication type:
- Article
Automated light-induced synthesis of <sup>89</sup>Zr-radiolabeled antibodies for immuno-positron emission tomography.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04626-5
- By:
- Publication type:
- Article
Frontispiece: Photochemical Conjugation and One‐Pot Radiolabelling of Antibodies for Immuno‐PET.
- Published in:
- 2019
- By:
- Publication type:
- Front Cover
Photochemical Conjugation and One‐Pot Radiolabelling of Antibodies for Immuno‐PET.
- Published in:
- Angewandte Chemie International Edition, 2019, v. 58, n. 7, p. 1928, doi. 10.1002/anie.201813287
- By:
- Publication type:
- Article
Synthesis and Evaluation of Biphenyl Compounds as Kinesin Spindle Protein Inhibitors.
- Published in:
- Chemistry & Biodiversity, 2013, v. 10, n. 4, p. 538, doi. 10.1002/cbdv.201200400
- By:
- Publication type:
- Article
Annotating MYC status with <sup>89</sup>Zr-transferrin imaging.
- Published in:
- Nature Medicine, 2012, v. 18, n. 10, p. 1586, doi. 10.1038/nm.2935
- By:
- Publication type:
- Article
Asymmetric rotaxanes as dual-modality supramolecular imaging agents for targeting cancer biomarkers.
- Published in:
- Communications Chemistry, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42004-023-00906-5
- By:
- Publication type:
- Article
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using <sup>89</sup>Zr-DFO-Trastuzumab.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008859
- By:
- Publication type:
- Article
Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 1, p. 95, doi. 10.1007/s11307-020-01530-8
- By:
- Publication type:
- Article
Light‐Activated Protein Conjugation and <sup>89</sup>Zr‐Radiolabelling with Water‐Soluble Desferrioxamine Derivatives.
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 32, p. 7185, doi. 10.1002/chem.202001755
- By:
- Publication type:
- Article
Cover Feature: Light‐Activated Protein Conjugation and <sup>89</sup>Zr‐Radiolabelling with Water‐Soluble Desferrioxamine Derivatives (Chem. Eur. J. 32/2020).
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 32, p. 7142, doi. 10.1002/chem.202001987
- By:
- Publication type:
- Article
Frontispiece: Photochemical Reactions in the Synthesis of Protein–Drug Conjugates.
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 1, p. N.PAG, doi. 10.1002/chem.202080162
- By:
- Publication type:
- Article
Photochemical Reactions in the Synthesis of Protein–Drug Conjugates.
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 1, p. 33, doi. 10.1002/chem.201904059
- By:
- Publication type:
- Article
Frontispiece: Chemical Kinetics of Radiolabelling Reactions.
- Published in:
- Chemistry - A European Journal, 2018, v. 24, n. 62, p. N.PAG, doi. 10.1002/chem.201886262
- By:
- Publication type:
- Article
Chemical Kinetics of Radiolabelling Reactions.
- Published in:
- Chemistry - A European Journal, 2018, v. 24, n. 62, p. 16472, doi. 10.1002/chem.201803261
- By:
- Publication type:
- Article
Supramolecular Rotaxane‐Based Multi‐Modal Probes for Cancer Biomarker Imaging**.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 29, p. 1, doi. 10.1002/ange.202204072
- By:
- Publication type:
- Article
Supramolecular Rotaxane‐Based Multi‐Modal Probes for Cancer Biomarker Imaging**.
- Published in:
- Angewandte Chemie International Edition, 2022, v. 61, n. 29, p. 1, doi. 10.1002/anie.202204072
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of 89ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 2, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
Light-induced radiosynthesis of <sup>89</sup>ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 1, p. 1, doi. 10.2967/jnumed.119.237180
- By:
- Publication type:
- Article
The impact of emerging bioconjugation chemistries on radiopharmaceuticals.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220806
- By:
- Publication type:
- Article
The Impact of Emerging Bioconjugation Chemistries on Radiopharmaceuticals.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 587, doi. 10.2967/jnumed.118.220806
- By:
- Publication type:
- Article
Advanced Methods for Radiolabeling Multimodality Nanomedicines for SPECT/MRI and PET/MRI.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 3, p. 382, doi. 10.2967/jnumed.116.187419
- By:
- Publication type:
- Article
Immuno-PET Imaging of CD30-Positive Lymphoma Using <sup>89</sup>Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 1, p. 96, doi. 10.2967/jnumed.115.162735
- By:
- Publication type:
- Article
Iodonium Ylide--Mediated Radiofluorination of <sup>18</sup>F-FPEB and Validation for Human Use.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 3, p. 489, doi. 10.2967/jnumed.114.151332
- By:
- Publication type:
- Article
Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with <sup>18</sup>F-FDG and <sup>89</sup>Zr-Trastuzumab PET.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 6, p. 936, doi. 10.2967/jnumed.112.110239
- By:
- Publication type:
- Article
Imaging Tumor Burden in the Brain with <sup>89</sup>Zr-Transferrin.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 1, p. 90, doi. 10.2967/jnumed.112.109777
- By:
- Publication type:
- Article
PET of Signal Transduction Pathways in Cancer.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1333, doi. 10.2967/jnumed.112.105387
- By:
- Publication type:
- Article
Targeting the Internal Epitope of Prostate-Specific Membrane Antigen with <sup>89</sup>Zr-7E11 Immuno-PET.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 10, p. 1608, doi. 10.2967/jnumed.111.092098
- By:
- Publication type:
- Article
Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: <sup>89</sup>Zr-Albumin as a Model System.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 4, p. 625, doi. 10.2967/jnumed.110.083998
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 8, p. 1293, doi. 10.2967/jnumed.110.076174
- By:
- Publication type:
- Article
Cerenkov Luminescence Imaging of Medical Isotopes.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 7, p. 1123, doi. 10.2967/jnumed.110.076521
- By:
- Publication type:
- Article
In Vitro and In Vivo Evaluations of a Hydrophilic <sup>64</sup>Cu-Bis(Thiosemicarbazonato)--Glucose Conjugate for Hypoxia Imaging.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 11, p. 1862, doi. 10.2967/jnumed.108.054015
- By:
- Publication type:
- Article
Spectroelectrochemical and Computational Studies on the Mechanism of Hypoxia Selectivity of Copper Radiopharmaceuticals.
- Published in:
- Chemistry - A European Journal, 2008, v. 14, n. 19, p. 5890, doi. 10.1002/chem.200800539
- By:
- Publication type:
- Article